Visiun releases innovative blood bank utilization system for laboratories and transfusion services

NewsGuard 100/100 Score

Visiun, Inc., the leader in performance analytics for the laboratory, announced today the release of a blood bank utilization module for laboratories and transfusion services across the nation. This comprehensive new system will change the way blood banks optimize patient blood management.

Blood banks will now be able to quickly identify how well hospital physicians are complying with transfusion service protocols in order to reduce inappropriate transfusions. Analysis of large-scale data will also allow the blood bank to review cross-matched to transfused ratios along with determining transfusion probabilities.

"Blood products are one of the largest line items in the health system's budget," says Thomas Joseph, Visiun's CEO. "Our new blood bank utilization system provides transfusion managers with the tools and insight to take preemptive measures to optimize patient blood management, thus saving money and improving patient care."

This new blood bank utilization system is the newest component of Visiun's core product, Performance Insight™. Performance Insight provides laboratory directors and managers with business intelligence and analytics to help their management teams monitor key performance indicators. Rich graphical reporting provides immediate insight into key aspects of laboratory performance including turnaround time, productivity, quality, test utilization, and blood bank utilization. Access to this type of reporting and analysis has transformed the way that managers and their teams are able to work together to meet the challenges of today's environment.

Source:

2016 AACC Annual Meeting Press Program

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Non-invasive blood test shows 83% sensitivity in detecting colorectal cancer, offering hope for early diagnosis